| Brand Name: | Sichuan Kelun Pharmaceutical Co., Ltd. |
| Model Number: | Olaparib KL-20243062 |
| MOQ: | Negotiable |
| Price: | Please contact a specialist WhatsApp:55342706 |
| Delivery Time: | Negotiable |
| Payment Terms: | Western Union,MoneyGram,T/T |
Generic Name: Olaparib
Specification: 150mg x 56 Tablets
Olaparib
1. BRCA-mutated advanced ovarian cancer maintenance. 2. HER2- metastatic breast cancer with gBRCA. 3. gBRCA-mutated metastatic pancreatic cancer. 4. mCRPC with HRR mutations.
PARP inhibitor trapping PARP on DNA, creating synthetic lethality in BRCA-mutated/HRD cancer cells deficient in homologous recombination repair.
300mg (2 tablets) twice daily. Total 600mg/day. Swallow whole. With or without food.
Nausea (77%), fatigue (67%), anemia (44%), vomiting, diarrhea. MDS/AML (rare but fatal), pneumonitis, VTE.
Store below 30C. Keep out of reach of children.
24 months
Approval: H20243062